November 8, 2005

"Stem Cell Research"

An informal discussion with

  Irving L. Weissman, M.D.

Karel H. and Avice N. Beekhuis Professor in Cancer Biology
Director, Institute for Cancer/Stem Cell Biology and Medicine
Stanford University School of Medicine

Tuesday November 8, 2005
6 to 7:30 p.m.

Dr. Weissman's field of research is adult tissue stem cell biology.  In 1988, he and his team were first to isolate any adult stem cell—the mouse hematopoietic (blood-forming) stem cell (HSC).  This was followed by the isolation of the human HSC, the human brain cell forming stem cell (CNS), and most or all blood system committed progenitors in mouse and man.  Dr. Weissman is a cofounder of the adult or tissue stem cell companies Stem Cells, Inc. and SyStemix, Inc (human HSC) which released the stem cell service transplant functions to Cellerant, Inc, to deliver human HSC and blood system progenitors to patient populations.  Dr. Weissman's July 2004 testimony before the U.S. Senate was one of the most remarkable testimonies.  He concluded by admonishing: "In my view it is irresponsible to fail to pursue all such avenues in parallel to stop or ameliorate the tragedies our families endure because of these diseases. And of course, in my view it is worse than irresponsible to ban these pursuits."